{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:42:15Z","timestamp":1777653735840,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["1H79TI085748"],"award-info":[{"award-number":["1H79TI085748"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.josat.2025.209622","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T08:00:47Z","timestamp":1736496047000},"page":"209622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The first five years of implementing Missouri's medication first approach to opioid use disorder treatment: Plateaus, regressions, and underbellies of progress"],"prefix":"10.1016","volume":"170","author":[{"given":"Rachel P.","family":"Winograd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Ghonasgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Thater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209622_bb0005","unstructured":"American Association for the Treatment of Opioid Dependence, Inc. (n.d.). Progress report. Retrieved May 8, 2024, from https:\/\/www.aatod.org\/advocacy\/policy-statements\/progress-report\/."},{"issue":"1","key":"10.1016\/j.josat.2025.209622_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-021-00424-4","article-title":"Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado","volume":"17","author":"Amura","year":"2022","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.josat.2025.209622_bb0015","series-title":"ASAM frequently asked questions","first-page":"1","year":"2024"},{"key":"10.1016\/j.josat.2025.209622_bb0020","doi-asserted-by":"crossref","DOI":"10.1007\/s40429-023-00489-0","article-title":"\u201cCulturally responsive\u201d substance use treatment: Contemporary definitions and approaches for minoritized racial\/ethnic groups","author":"Banks","year":"2023","journal-title":"Current Addiction Reports"},{"issue":"3","key":"10.1016\/j.josat.2025.209622_bb0025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/add.15362","article-title":"Commentary on Furr-Holden et al.: As opioid overdose deaths accelerate among black Americans, COVID-19 widens inequities-a critical need to invest in community-based approaches","volume":"116","author":"Banks","year":"2021","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.josat.2025.209622_bb0030","series-title":"Examining increasing racial inequities in opioid overdose deaths: A spatiotemporal analysis of black and white decedents in St. Louis, Missouri, 2011\u20132021","author":"Banks","year":"2023"},{"key":"10.1016\/j.josat.2025.209622_bb0035","series-title":"Stochastic modeling","article-title":"Akaike information criterion\u2014An overview | ScienceDirect topics","author":"Bonakdari","year":"2022"},{"issue":"12","key":"10.1016\/j.josat.2025.209622_bb0040","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/add.15959","article-title":"Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: A retrospective cohort study","volume":"117","author":"Burns","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209622_bb4010","series-title":"Uninsured in Missouri: Who remains uninsured and why it matters [Issue brief]. Washington University in St. Louis","author":"CAHSPER","year":"2024"},{"key":"10.1016\/j.josat.2025.209622_bb0045","series-title":"Increased use of telehealth services and medications for opioid use disorder during the COVID-19 pandemic associated with reduced risk for fatal overdose [press release]","author":"CDC Newsroom","year":"2023"},{"key":"10.1016\/j.josat.2025.209622_bb0050","doi-asserted-by":"crossref","DOI":"10.15190\/d.2021.20","article-title":"Substance use during COVID-19 pandemic: Impact on the underserved communities","volume":"9","author":"Chacon","year":"2021","journal-title":"Discoveries"},{"issue":"9","key":"10.1016\/j.josat.2025.209622_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.josat.2025.209622_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10488-020-01041-2","article-title":"Strategies for sustaining fidelity: A multi-state qualitative analysis in housing first programs","volume":"48","author":"Choy-Brown","year":"2021","journal-title":"Administration and Policy in Mental Health and Mental Health Services Research"},{"issue":"1","key":"10.1016\/j.josat.2025.209622_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jamapsychiatry.2022.3673","article-title":"Racial and ethnic disparities in buprenorphine treatment duration in the US","volume":"80","author":"Dong","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.josat.2025.209622_bb0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amepre.2022.05.006","article-title":"Racial\u2013ethnic disparities of buprenorphine and vivitrol receipt in medicaid","volume":"63","author":"Dunphy","year":"2022","journal-title":"American Journal of Preventive Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209622_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40488-021-00121-4","article-title":"A comparison of zero-inflated and hurdle models for modeling zero-inflated count data","volume":"8","author":"Feng","year":"2021","journal-title":"Journal of Statistical Distributions and Applications"},{"key":"10.1016\/j.josat.2025.209622_bb0080","series-title":"An R companion to applied regression","author":"Fox","year":"2019"},{"key":"10.1016\/j.josat.2025.209622_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103715","article-title":"A mixed methods study of provider factors in buprenorphine treatment retention","volume":"105","author":"Gertner","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209622_bb0090","series-title":"Repercussions of multicollinearity in binary logistic regression (master of science in mathematics. 30)","author":"Ghaner","year":"2022"},{"issue":"12","key":"10.1016\/j.josat.2025.209622_bb0095","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapsychiatry.2022.3118","article-title":"Association between buprenorphine treatment gaps, opioid overdose, and health care spending in US Medicare beneficiaries with opioid use disorder","volume":"79","author":"Gibbons","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2025.209622_bb0100","series-title":"As fatal overdoses rise, many Americans see drug addiction as a major problem in their community","author":"Gramlich","year":"2018"},{"issue":"5","key":"10.1016\/j.josat.2025.209622_bb0105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/ADM.0000000000001189","article-title":"Evidence on buprenorphine dose limits: A review","volume":"17","author":"Grande","year":"2023","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209622_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.52381","article-title":"Telemedicine use and quality of opioid use disorder treatment in the US during the COVID-19 pandemic","volume":"6","author":"Hailu","year":"2023","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.josat.2025.209622_bb0115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals","volume":"46","author":"Hall","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209622_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108805","article-title":"\u201cCan we get a Black rehabilitation center\u201d? Factors impacting the treatment experiences of Black people who use opioids","author":"Hargons","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209622_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109383","article-title":"Substance use disorders and COVID-19: An analysis of nation-wide veterans health administration electronic health records","volume":"234","author":"Hasin","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2025.209622_bb0130","first-page":"60","article-title":"Making fidelity an intramural game: Localizing quality assurance procedures to promote sustainability of evidence-based practices in usual care","volume":"20","author":"Hogue","year":"2013","journal-title":"Clinical Psychology: Science and Practice"},{"issue":"3","key":"10.1016\/j.josat.2025.209622_bb0135","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08897077.2019.1635557","article-title":"Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from Seattle, Washington","volume":"41","author":"Hood","year":"2020","journal-title":"Substance Abuse"},{"issue":"5","key":"10.1016\/j.josat.2025.209622_bb0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/00952990.2011.597280","article-title":"Zero-inflated and hurdle models of count data with extra Zeros: Examples from an HIV-risk reduction intervention trial","volume":"37","author":"Hu","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2025.209622_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209361","article-title":"Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults","author":"Jaffe","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"2","key":"10.1016\/j.josat.2025.209622_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ADM.0000000000000555","article-title":"Defining low-threshold buprenorphine treatment","volume":"14","author":"Jakubowski","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"17","key":"10.1016\/j.josat.2025.209622_bb0155","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.2018.2844","article-title":"Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016","volume":"319","author":"Jones","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.josat.2025.209622_bb0160","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s11606-020-06409-6","article-title":"A harm reduction approach to treating opioid use disorder in an independent primary care practice: A qualitative study","volume":"36","author":"Kapadia","year":"2021","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2025.209622_bb0165","series-title":"Methadone reform has gone beyond debate to proposed legislation, SAMHSA rule changes","author":"Knopf","year":"2022"},{"issue":"20","key":"10.1016\/j.josat.2025.209622_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/adaw.33782","article-title":"SAMHSA and FDA move toward \u2018medication only\u2019","volume":"35","author":"Knopf","year":"2023","journal-title":"Alcoholism & Drug Abuse Weekly"},{"key":"10.1016\/j.josat.2025.209622_bb0175","author":"Koenker"},{"issue":"3","key":"10.1016\/j.josat.2025.209622_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/j.josat.2025.209622_bb0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/ajad.12925","article-title":"Brief report: Low-barrier buprenorphine initiation predicts treatment retention among Latinx and non-Latinx primary care patients","volume":"28","author":"Lee","year":"2019","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2025.209622_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108544","article-title":"The impact of COVID-19 on substance use disorder treatment in California: Service providers\u2019 perspectives","volume":"133","author":"Lin","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209622_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109711","article-title":"Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States","volume":"242","author":"Lin","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2025.209622_bb0200","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.amepre.2022.04.021","article-title":"American College of Preventive Medicine: Addressing the opioid epidemic through a prevention framework","volume":"63","author":"Livingston","year":"2022","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.josat.2025.209622_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104318","article-title":"Association between high-threshold practices and buprenorphine treatment termination","volume":"124","author":"Lyle","year":"2024","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209622_bb0210","article-title":"Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis","volume":"1","author":"Ma","year":"2018","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"10.1016\/j.josat.2025.209622_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1037\/a0018121","article-title":"The dissemination and implementation of evidence-based psychological treatments: A review of current efforts","volume":"65","author":"McHugh","year":"2010","journal-title":"American Psychologist"},{"key":"10.1016\/j.josat.2025.209622_bb0220","unstructured":"Medication first implementation. (n.d.). NoMoDeaths. Retrieved May 8, 2024, from https:\/\/www.nomodeaths.org\/medication-first-implementation."},{"key":"10.1016\/j.josat.2025.209622_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209054","article-title":"Outcomes of a mobile medical unit for low-threshold buprenorphine access targeting opioid overdose hot spots in Chicago","volume":"150","author":"Messmer","year":"2023","journal-title":"Journal of Substance Use & Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209622_bb0230","series-title":"Mplus discussion\u00a0\u226b\u00a0Intraclass correlations","author":"Muth\u00e9n","year":"1999"},{"key":"10.1016\/j.josat.2025.209622_bb0235","series-title":"Drug overdose death rates","author":"National Institute on Drug Abuse","year":"2023"},{"issue":"1","key":"10.1016\/j.josat.2025.209622_bb0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11606-023-08383-1","article-title":"Telehealth initiation of buprenorphine for opioid use disorder: Patient characteristics and outcomes","volume":"39","author":"Nguyen","year":"2024","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2025.209622_bb4005","unstructured":"NoMO Deaths (n.d.). Findings: No MO deaths. Retrieved May 1, 2024, from https:\/\/www.nomodeaths.com\/findings."},{"issue":"1","key":"10.1016\/j.josat.2025.209622_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40352-024-00266-9","article-title":"Rural and urban clinician views on COVID-19\u2019s impact on substance use treatment for individuals on community supervision in Kentucky","volume":"12","author":"Oser","year":"2024","journal-title":"Health & Justice"},{"key":"10.1016\/j.josat.2025.209622_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108255","article-title":"Impacts of COVID-19 on residential treatment programs for substance use disorder","volume":"123","author":"Pagano","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209622_bb0260","unstructured":"Penn State, Department of Statistics. (n.d.). 7.3\u2014Overdispersion. Penn State Eberly College of Science. https:\/\/online.stat.psu.edu\/stat504\/lesson\/7\/7.3."},{"key":"10.1016\/j.josat.2025.209622_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1154813","article-title":"A mobile addiction service for community-based overdose prevention","volume":"11","author":"Pepin","year":"2023","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.josat.2025.209622_bb0270","series-title":"Preparing the specialty SUD system in Los Angeles county for payment reform","year":"2023"},{"key":"10.1016\/j.josat.2025.209622_bb0275","series-title":"R: A language and environment for statistical computing. [Computer software]","author":"R Core Team","year":"2024"},{"key":"10.1016\/j.josat.2025.209622_bb0280","unstructured":"Reaching the 95% (R95) initiative. (n.d.). County of Los Angeles Public Health. Retrieved May 8, 2024, from http:\/\/publichealth.lacounty.gov\/sapc\/public\/reaching-the-95.htm?hl."},{"key":"10.1016\/j.josat.2025.209622_bb0285","series-title":"Infographic: Fentanyl fuels surge in U.S. drug overdose deaths","author":"Richter","year":"2022"},{"key":"10.1016\/j.josat.2025.209622_bb0290","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1016\/j.josat.2025.209622_bb0300","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/10550887.2012.694603","article-title":"Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in new York City: The need to expand access to buprenorphine\/naloxone in marginalized populations","volume":"31","author":"Stancliff","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"33","key":"10.1016\/j.josat.2025.209622_bb0305","article-title":"Letter to the editor: \u2018Medication first\u2019 not the same as \u2018medication only\u2019","volume":"30","author":"Stringer","year":"2018","journal-title":"Alcoholism & Drug Abuse Weekly"},{"key":"10.1016\/j.josat.2025.209622_bb0310","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2025.209622_bb0315","unstructured":"The Comprehensive R Archive Network. (n.d.). Count data and overdispersion. https:\/\/cran.r-project.org\/web\/packages\/GlmSimulatoR\/vignettes\/count_data_and_overdispersion.html."},{"key":"10.1016\/j.josat.2025.209622_bb0320","series-title":"ICYMI: Biden-Harris administration announces $450M to support President Biden\u2019s Unity agenda efforts to beat the overdose epidemic & save lives | ONDCP","author":"The White House","year":"2023"},{"issue":"9","key":"10.1016\/j.josat.2025.209622_bb0325","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2105\/AJPH.2020.305835","article-title":"Is the housing first model effective? Different evidence for different outcomes","volume":"110","author":"Tsai","year":"2020","journal-title":"American Journal of Public Health"},{"issue":"4","key":"10.1016\/j.josat.2025.209622_bb0330","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2105\/AJPH.94.4.651","article-title":"Housing first, consumer choice, and harm reduction for homeless individuals with a dual diagnosis","volume":"94","author":"Tsemberis","year":"2004","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2025.209622_bb4000","series-title":"Missouri: 2020 census","author":"U.S. Census Bureau","year":"2021"},{"issue":"4","key":"10.1016\/j.josat.2025.209622_bb0335","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/ADM.0000000000000922","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl","volume":"16","author":"Varshneya","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"14","key":"10.1016\/j.josat.2025.209622_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19148883","article-title":"Illicit substance use and the COVID-19 pandemic in the United States: A scoping review and characterization of research evidence in unprecedented times","volume":"19","author":"Vo","year":"2022","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"2","key":"10.1016\/j.josat.2025.209622_bb0345","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2025.209622_bb0350","series-title":"Outcomes of State targeted\/opioid response grants and the medication first approach: Evidence of racial inequities in improved treatment access and retention","author":"Winograd","year":"2023"},{"key":"10.1016\/j.josat.2025.209622_bb0355","doi-asserted-by":"crossref","DOI":"10.1080\/00952990.2019.1605372","article-title":"The case for a medication first approach to the treatment of opioid use disorder","author":"Winograd","year":"2019","journal-title":"American Journal of Drug and Alcohol Abuse."},{"issue":"2","key":"10.1016\/j.josat.2025.209622_bb0360","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/08897077.2019.1616348","article-title":"Concerns that an opioid antidote could \u201cmake things worse\u201d: Profiles of risk compensation beliefs using the naloxone-related risk compensation beliefs (NaRRC-B) scale","volume":"41","author":"Winograd","year":"2020","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2025.209622_bb0365","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsat.2019.06.015","article-title":"Implementation and evaluation of Missouri\u2019s medication first treatment approach for opioid use disorder in publicly-funded substance use treatment programs","volume":"108","author":"Winograd","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"8","key":"10.1016\/j.josat.2025.209622_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v027.i08","article-title":"Regression models for count data in R","volume":"27","author":"Zeileis","year":"2008","journal-title":"Journal of Statistical Software"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T20:13:44Z","timestamp":1741032824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":75,"alternative-id":["S2949875925000013"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209622","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The first five years of implementing Missouri's medication first approach to opioid use disorder treatment: Plateaus, regressions, and underbellies of progress","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209622"}}